Investigating the role of a protein in aggressive kidney cancer and its treatment potential
The role of Angiopoietin-like 4 in clear cell renal cell carcinoma and its therapeutic potential
This study is looking at how a protein called ANGPTL4 affects kidney cancer growth and whether blocking it can help make treatments work better for people with clear cell renal cell carcinoma.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11047156 on NIH RePORTER |
What this research studies
This research focuses on clear cell renal cell carcinoma (ccRCC), a common and aggressive type of kidney cancer. It aims to understand the role of Angiopoietin-like 4 (ANGPTL4), a protein that may influence tumor growth and blood vessel formation. The researchers will explore how blocking ANGPTL4 can reduce tumor growth and improve the effectiveness of existing cancer therapies. By identifying patient groups that may benefit from this approach, the study seeks to enhance treatment outcomes for ccRCC patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with clear cell renal cell carcinoma who may not respond well to current therapies.
Not a fit: Patients with other types of kidney cancer or those who have already responded well to existing treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with clear cell renal cell carcinoma.
How similar studies have performed: Previous research has shown promising results in targeting angiogenesis in cancer treatment, suggesting that this approach may be effective.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Kolb, Ryan H — University of Florida
- Study coordinator: Kolb, Ryan H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.